RETROFIT Platform shared on LinkedIn:
“RETROFIT team is heading to Biovia Science for health immunology event (SfH2026) to present an oral presentation highlighting the platform and pitching our lead multispecific asset, RF-001.
RETROFIT platform: lab-in-the-loop powered by AI for next-gen immunotherapy.
This reflects our efforts to develop next-generation first-in-class immunotherapies against the root causes of resistance and underscores the strength of our discovery platform.
We look forward to the pitch and engaging in discussions that advance the field for patients who are left behind by current therapies.”
You can also read:
Agentic AI for Immune-Related Adverse Event Detection in Cancer Immunotherapy
